A national framework designed to support the standardisation and expansion of advanced therapy clinical trials. The framework is organised around the typical lifecycle of advanced therapy medicinal product clinical trial activity and comprises five interconnected dimensions: initial sponsor engagement, trial set-up, trial delivery, trial close-out and long-term follow-up.